enow.com Web Search

  1. Ads

    related to: new treatment for migraine headaches in adults

Search results

  1. Results from the WOW.Com Content Network
  2. This New Nasal Spray Could Provide Migraine Relief in ... - AOL

    www.aol.com/nasal-spray-could-migraine-relief...

    Zavzpret is a new nasal spray to treat migraine headaches in adults. But how does the medication work and who should try the new FDA-approved medication?

  3. Management of migraine - Wikipedia

    en.wikipedia.org/wiki/Management_of_migraine

    Rescue treatment involves acute symptomatic control with medication. [4] Recommendations for rescue therapy of migraine include: (1) migraine-specific agents such as triptans, CGRP antagonists, or ditans for patients with severe headaches or for headaches that respond poorly to analgesics, (2) non-oral (typically nasal or injection) route of administration for patients with vomiting, (3) avoid ...

  4. FDA approves Pfizer's new nasal spray treatment for migraines

    www.aol.com/entertainment/fda-approves-pfizers...

    Migraines are one of the most common debilitating medical conditions, said Dr. Leah Croll, a board-certified neurologist at the Le FDA approves Pfizer's new nasal spray treatment for migraines ...

  5. Why it’s so important to get help for migraine attacks - AOL

    www.aol.com/why-important-help-migraine-attacks...

    Olivia Begasse de Dhaem, M.D., a board-certified neurologist and headache specialist, and a member of the American Headache Society, has more to add: “Without treatment, migraine can interfere ...

  6. Atogepant - Wikipedia

    en.wikipedia.org/wiki/Atogepant

    Atogepant is indicated for the preventive treatment of episodic migraine in adults. [ 4 ] [ 5 ] In the European Union, atogepant (Aquipta) is indicated for prophylaxis (prevention) of migraine in adults who have at least four migraine days per month.

  7. Antimigraine drug - Wikipedia

    en.wikipedia.org/wiki/Antimigraine_drug

    Opioids are not recommended for treatment of acute migraines due to their significant side effect profile, including twice the risk of medication overuse headache when compared to NSAIDS, acetaminophen or triptans. [3] In addition, their strength of efficacy has showed to be low or insufficient for pain relief of migraines. [3]

  1. Ads

    related to: new treatment for migraine headaches in adults